Solventum Corp
SOLV- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001964738
No open-market purchases or sales by Solventum Corp insiders were filed in the last 90 days; 885 institutions reported holding it in 13F filings for Q2 2026, worth $9.84B in total; Trian Fund Management is the only superinvestor holding it.
Superinvestors holding SOLV, Q2 2026
1 superinvestor reports holding Solventum Corp on Form 13F, worth $635.5M in total. Weight is Solventum Corp's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Trian Fund ManagementNelson Peltz | 15.0% | 8,236,753 | $635.5M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SOLV each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2025
1 superinvestor holding at quarter end
- Reduced
- Trian Fund Management (−2.7%)
Q2 2025
1 superinvestor holding at quarter end
- Sold out
- Baupost Group
Q1 2025
2 superinvestors holding at quarter end
- Reduced
- Baupost Group (−27.2%)
Q4 2024
2 superinvestors holding at quarter end
- Added
- Trian Fund Management (+18.8%)
- Reduced
- Baupost Group (−20.5%)
- Sold out
- Markel Group
Q3 2024
3 superinvestors holding at quarter end
- Added
- Trian Fund Management (+32.9%)
- Reduced
- Markel Group (−99.0%)
- Sold out
- Soros Fund Management
Q2 2024
4 superinvestors holding at quarter end
- New
- Trian Fund Management, Baupost Group, Markel Group
- Added
- Soros Fund Management (+200.0%)
Q1 2024
1 superinvestor holding at quarter end